RARRES2 and polycystic ovary syndrome: In conclusion, to the best of our knowledge, the present study is the first to document the effect of VD3 supplementation on the plasma levels of RARRES2 and ADIPOQ, as well as their transcript and protein expression in the uterus of PCOS rats.